Skip to main content
Erschienen in: Abdominal Radiology 4/2019

25.10.2018

Investigating the role of DCE-MRI, over T2 and DWI, in accurate PI-RADS v2 assessment of clinically significant peripheral zone prostate lesions as defined at radical prostatectomy

verfasst von: Mehdi Taghipour, Alireza Ziaei, Francesco Alessandrino, Elmira Hassanzadeh, Mukesh Harisinghani, Mark Vangel, Clare M. Tempany, Fiona M. Fennessy

Erschienen in: Abdominal Radiology | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

PI-RADS v2 dictates that dynamic contrast-enhanced (DCE) imaging be used to further classify peripheral zone (PZ) cases that receive a diffusion-weighted imaging equivocal score of three (DWI3), a positive DCE resulting in an increase in overall assessment score to a four, indicative of clinically significant prostate cancer (csPCa). However, the accuracy of DCE in predicting csPCa in DWI3 PZ cases is unknown. This study sought to determine the frequency with which DCE changes the PI-RADS v2 DWI3 assessment category, and to determine the overall accuracy of DCE-MRI in equivocal PZ DWI3 lesions.

Materials and Methods

This is a retrospective study of patients with pathologically proven PCa who underwent prostate mpMRI at 3T and subsequent radical prostatectomy. PI-RADS v2 assessment categories were determined by a radiologist, aware of a diagnosis of PCa, but blinded to final pathology. csPCa was defined as a Gleason score ≥ 7 or extra prostatic extension at pathology review. Performance characteristics and diagnostic accuracy of DCE in assigning a csPCa assessment in PZ lesions were calculated.

Results

A total of 271 men with mean age of 59 ± 6 years mean PSA 6.7 ng/mL were included. csPCa was found in 212/271 (78.2%) cases at pathology, 209 of which were localized in the PZ. DCE was necessary to further classify (45/209) of patients who received a score of DWI3. DCE was positive in 29/45 cases, increasing the final PI-RADS v2 assessment category to a category 4, with 16/45 having a negative DCE. When compared with final pathology, DCE was correct in increasing the assessment category in 68.9% ± 7% (31/45) of DWI3 cases.

Conclusion

DCE increases the accuracy of detection of csPCa in the majority of PZ lesions that receive an equivocal PI-RADS v2 assessment category using DWI.
Literatur
1.
Zurück zum Zitat American Cancer Society (2016) Cancer Facts & Figures 2016. Atlanta: American Cancer Society www.cancer.org. Accessed Sept 8 2018. American Cancer Society (2016) Cancer Facts & Figures 2016. Atlanta: American Cancer Society www.​cancer.​org. Accessed Sept 8 2018.
2.
Zurück zum Zitat Hassanzadeh E, Glazer DI, Dunne RM, et al. (2017) Prostate imaging reporting and data system version 2 (PI-RADS v2): a pictorial review. Abdom Radiol 42(1):278–289CrossRef Hassanzadeh E, Glazer DI, Dunne RM, et al. (2017) Prostate imaging reporting and data system version 2 (PI-RADS v2): a pictorial review. Abdom Radiol 42(1):278–289CrossRef
3.
Zurück zum Zitat Turkbey B, Brown AM, Sankineni S, et al. (2016) Multiparametric prostate magnetic resonance imaging in the evaluation of prostate cancer. CA 66(4):326–336PubMed Turkbey B, Brown AM, Sankineni S, et al. (2016) Multiparametric prostate magnetic resonance imaging in the evaluation of prostate cancer. CA 66(4):326–336PubMed
4.
Zurück zum Zitat Penzkofer T, Tuncali K, Fedorov A, et al. (2014) Transperineal in-bore 3-T MR imaging–guided prostate biopsy: a prospective clinical observational study. Radiology 274(1):170–180PubMedPubMedCentralCrossRef Penzkofer T, Tuncali K, Fedorov A, et al. (2014) Transperineal in-bore 3-T MR imaging–guided prostate biopsy: a prospective clinical observational study. Radiology 274(1):170–180PubMedPubMedCentralCrossRef
5.
Zurück zum Zitat Fennessy FM, Tuncali K, Morrison PR, Tempany CM (2010) Mr imaging–guided interventions in the genitourinary tract: an evolving concept. Magn Reson Imaging Clin 18(1):11–28CrossRef Fennessy FM, Tuncali K, Morrison PR, Tempany CM (2010) Mr imaging–guided interventions in the genitourinary tract: an evolving concept. Magn Reson Imaging Clin 18(1):11–28CrossRef
8.
Zurück zum Zitat Hansford BG, Peng Y, Jiang Y, et al. (2015) Dynamic contrast-enhanced MR imaging curve-type analysis: is it helpful in the differentiation of prostate cancer from healthy peripheral zone? Radiology 275(2):448–457PubMedCrossRef Hansford BG, Peng Y, Jiang Y, et al. (2015) Dynamic contrast-enhanced MR imaging curve-type analysis: is it helpful in the differentiation of prostate cancer from healthy peripheral zone? Radiology 275(2):448–457PubMedCrossRef
9.
Zurück zum Zitat Platzek I, Borkowetz A, Toma M, et al. (2015) Multiparametric prostate magnetic resonance imaging at 3 T: failure of magnetic resonance spectroscopy to provide added value. J Comput Assist Tomogr 39(5):674–680PubMedCrossRef Platzek I, Borkowetz A, Toma M, et al. (2015) Multiparametric prostate magnetic resonance imaging at 3 T: failure of magnetic resonance spectroscopy to provide added value. J Comput Assist Tomogr 39(5):674–680PubMedCrossRef
10.
Zurück zum Zitat Tan CH, Paul Hobbs B, Wei W, Kundra V (2015) Dynamic contrast-enhanced MRI for the detection of prostate cancer: meta-analysis. Am J Roentgenol 204(4):W439–W448CrossRef Tan CH, Paul Hobbs B, Wei W, Kundra V (2015) Dynamic contrast-enhanced MRI for the detection of prostate cancer: meta-analysis. Am J Roentgenol 204(4):W439–W448CrossRef
11.
Zurück zum Zitat Weinreb JC, Barentsz JO, Choyke PL, et al. (2016) PI-RADS prostate imaging–reporting and data system: 2015, version 2. Eur Urol 69(1):16–40PubMedCrossRef Weinreb JC, Barentsz JO, Choyke PL, et al. (2016) PI-RADS prostate imaging–reporting and data system: 2015, version 2. Eur Urol 69(1):16–40PubMedCrossRef
12.
Zurück zum Zitat Park SY, Jung DC, Oh YT, et al. (2016) Prostate cancer: PI-RADS version 2 helps preoperatively predict clinically significant cancers. Radiology 280(1):108–116PubMedCrossRef Park SY, Jung DC, Oh YT, et al. (2016) Prostate cancer: PI-RADS version 2 helps preoperatively predict clinically significant cancers. Radiology 280(1):108–116PubMedCrossRef
13.
Zurück zum Zitat Rosenkrantz AB, Verma S, Turkbey B (2015) Prostate cancer: top places where tumors hide on multiparametric MRI. Am J Roentgenol 204(4):W449–W456CrossRef Rosenkrantz AB, Verma S, Turkbey B (2015) Prostate cancer: top places where tumors hide on multiparametric MRI. Am J Roentgenol 204(4):W449–W456CrossRef
15.
Zurück zum Zitat Tewes S, Mokov N, Hartung D, et al. (2016) Standardized reporting of prostate MRI: comparison of the prostate imaging reporting and data system (PI-RADS) version 1 and version 2. PLoS ONE 11(9):e0162879PubMedPubMedCentralCrossRef Tewes S, Mokov N, Hartung D, et al. (2016) Standardized reporting of prostate MRI: comparison of the prostate imaging reporting and data system (PI-RADS) version 1 and version 2. PLoS ONE 11(9):e0162879PubMedPubMedCentralCrossRef
16.
Zurück zum Zitat Rosenkrantz AB, Babb JS, Taneja SS, Ream JM (2016) Proposed adjustments to PI-RADS version 2 decision rules: impact on prostate cancer detection. Radiology 283(1):119–129PubMedCrossRef Rosenkrantz AB, Babb JS, Taneja SS, Ream JM (2016) Proposed adjustments to PI-RADS version 2 decision rules: impact on prostate cancer detection. Radiology 283(1):119–129PubMedCrossRef
17.
Zurück zum Zitat Rosenkrantz AB, Ginocchio LA, Cornfeld D, et al. (2016) Interobserver reproducibility of the PI-RADS version 2 lexicon: a multicenter study of six experienced prostate radiologists. Radiology 280(3):793–804PubMedPubMedCentralCrossRef Rosenkrantz AB, Ginocchio LA, Cornfeld D, et al. (2016) Interobserver reproducibility of the PI-RADS version 2 lexicon: a multicenter study of six experienced prostate radiologists. Radiology 280(3):793–804PubMedPubMedCentralCrossRef
18.
Zurück zum Zitat Zobel BB, Quattrocchi CC, Errante Y, Grasso RF (2016) Gadolinium-based contrast agents: did we miss something in the last 25 years? Radiol Med 121(6):478–481CrossRef Zobel BB, Quattrocchi CC, Errante Y, Grasso RF (2016) Gadolinium-based contrast agents: did we miss something in the last 25 years? Radiol Med 121(6):478–481CrossRef
19.
Zurück zum Zitat Idée JM, Fretellier N, Robic C, Corot C (2014) The role of gadolinium chelates in the mechanism of nephrogenic systemic fibrosis: a critical update. Crit Revs in Toxicol 44(10):895–913CrossRef Idée JM, Fretellier N, Robic C, Corot C (2014) The role of gadolinium chelates in the mechanism of nephrogenic systemic fibrosis: a critical update. Crit Revs in Toxicol 44(10):895–913CrossRef
20.
Zurück zum Zitat Darrah TH, Prutsman-Pfeiffer JJ, Poreda RJ, et al. (2009) Incorporation of excess gadolinium into human bone from medical contrast agents. Metallomics 1(6):479–488PubMedCrossRef Darrah TH, Prutsman-Pfeiffer JJ, Poreda RJ, et al. (2009) Incorporation of excess gadolinium into human bone from medical contrast agents. Metallomics 1(6):479–488PubMedCrossRef
21.
Zurück zum Zitat McDonald RJ, McDonald JS, Kallmes DF, et al. (2015) Intracranial gadolinium deposition after contrast-enhanced MR imaging. Radiology 275(3):772–782PubMedCrossRef McDonald RJ, McDonald JS, Kallmes DF, et al. (2015) Intracranial gadolinium deposition after contrast-enhanced MR imaging. Radiology 275(3):772–782PubMedCrossRef
22.
Zurück zum Zitat Fennessy FM, Fedorov A, Penzkofer T, et al. (2015) Quantitative pharmacokinetic analysis of prostate cancer DCE-MRI at 3 T: comparison of two arterial input functions on cancer detection with digitized whole mount histopathological validation. Magn Reson Imaging 33(7):886–894PubMedPubMedCentralCrossRef Fennessy FM, Fedorov A, Penzkofer T, et al. (2015) Quantitative pharmacokinetic analysis of prostate cancer DCE-MRI at 3 T: comparison of two arterial input functions on cancer detection with digitized whole mount histopathological validation. Magn Reson Imaging 33(7):886–894PubMedPubMedCentralCrossRef
23.
Zurück zum Zitat Fedorov A, Beichel R, Kalpathy-Cramer J, et al. (2012) 3D Slicer as an image computing platform for the Quantitative Imaging Network. M Magn Reson Imaging 30(9):1323–1341CrossRef Fedorov A, Beichel R, Kalpathy-Cramer J, et al. (2012) 3D Slicer as an image computing platform for the Quantitative Imaging Network. M Magn Reson Imaging 30(9):1323–1341CrossRef
24.
Zurück zum Zitat Kasivisvanathan V, Rannikko AS, Borghi M, et al. (2018) MRI-targeted or standard biopsy for prostate-cancer diagnosis. N Engl J Med 378(19):1767–1777PubMedCrossRef Kasivisvanathan V, Rannikko AS, Borghi M, et al. (2018) MRI-targeted or standard biopsy for prostate-cancer diagnosis. N Engl J Med 378(19):1767–1777PubMedCrossRef
25.
Zurück zum Zitat Fedorov A, Penzkofer T, Hirsch MS, et al. (2015) The role of pathology correlation approach in prostate cancer index lesion detection and quantitative analysis with multiparametric MRI. Acad Radiol 22(5):548–555PubMedPubMedCentralCrossRef Fedorov A, Penzkofer T, Hirsch MS, et al. (2015) The role of pathology correlation approach in prostate cancer index lesion detection and quantitative analysis with multiparametric MRI. Acad Radiol 22(5):548–555PubMedPubMedCentralCrossRef
26.
Zurück zum Zitat Zhang L, Tang M, Chen S, et al. (2017) A meta-analysis of use of Prostate Imaging Reporting and Data System Version 2 (PI-RADS V2) with multiparametric MR imaging for the detection of prostate cancer. Eur Radiol 27(12):5204–5214PubMedCrossRef Zhang L, Tang M, Chen S, et al. (2017) A meta-analysis of use of Prostate Imaging Reporting and Data System Version 2 (PI-RADS V2) with multiparametric MR imaging for the detection of prostate cancer. Eur Radiol 27(12):5204–5214PubMedCrossRef
27.
Zurück zum Zitat De Visschere PI, Lumen N, Ost P, et al. (2017) Dynamic contrast-enhanced imaging has limited added value over T2-weighted imaging and diffusion-weighted imaging when using PI-RADSv2 for diagnosis of clinically significant prostate cancer in patients with elevated PSA. Clin Radiol 72(1):23–32PubMedCrossRef De Visschere PI, Lumen N, Ost P, et al. (2017) Dynamic contrast-enhanced imaging has limited added value over T2-weighted imaging and diffusion-weighted imaging when using PI-RADSv2 for diagnosis of clinically significant prostate cancer in patients with elevated PSA. Clin Radiol 72(1):23–32PubMedCrossRef
28.
Zurück zum Zitat Epstein JI, Feng Z, Trock BJ, Pierorazio PM (2012) Upgrading and downgrading of prostate cancer from biopsy to radical prostatectomy: incidence and predictive factors using the modified Gleason grading system and factoring in tertiary grades. Eur Urol 61(5):1019–1024PubMedPubMedCentralCrossRef Epstein JI, Feng Z, Trock BJ, Pierorazio PM (2012) Upgrading and downgrading of prostate cancer from biopsy to radical prostatectomy: incidence and predictive factors using the modified Gleason grading system and factoring in tertiary grades. Eur Urol 61(5):1019–1024PubMedPubMedCentralCrossRef
29.
Zurück zum Zitat D’Elia C, Cerruto MA, Cioffi A, et al. (2014) Upgrading and upstaging in prostate cancer: from prostate biopsy to radical prostatectomy. Mol Clin Oncol 2(6):1145–1149PubMedPubMedCentralCrossRef D’Elia C, Cerruto MA, Cioffi A, et al. (2014) Upgrading and upstaging in prostate cancer: from prostate biopsy to radical prostatectomy. Mol Clin Oncol 2(6):1145–1149PubMedPubMedCentralCrossRef
30.
Zurück zum Zitat Thestrup KC, Logager V, Baslev I, et al. (2016) Biparametric versus multiparametric MRI in the diagnosis of prostate cancer. Acta Radiol Open 5(8):2058460116663046PubMedPubMedCentral Thestrup KC, Logager V, Baslev I, et al. (2016) Biparametric versus multiparametric MRI in the diagnosis of prostate cancer. Acta Radiol Open 5(8):2058460116663046PubMedPubMedCentral
31.
Zurück zum Zitat Fusco R, Sansone M, Petrillo M, et al. (2016) Multiparametric MRI for prostate cancer detection: preliminary results on quantitative analysis of dynamic contrast enhanced imaging, diffusion-weighted imaging and spectroscopy imaging. Magn Reson Imaging 34(7):839–845PubMedCrossRef Fusco R, Sansone M, Petrillo M, et al. (2016) Multiparametric MRI for prostate cancer detection: preliminary results on quantitative analysis of dynamic contrast enhanced imaging, diffusion-weighted imaging and spectroscopy imaging. Magn Reson Imaging 34(7):839–845PubMedCrossRef
32.
Zurück zum Zitat Dinh CV, Steenbergen P, Ghobadi G, et al. (2016) Magnetic resonance imaging for prostate cancer radiotherapy. Phys Med 32(3):446–451PubMedCrossRef Dinh CV, Steenbergen P, Ghobadi G, et al. (2016) Magnetic resonance imaging for prostate cancer radiotherapy. Phys Med 32(3):446–451PubMedCrossRef
33.
Zurück zum Zitat Barrett T, Gill AB, Kataoka MY, et al. (2012) DCE and DW MRI in monitoring response to androgen deprivation therapy in patients with prostate cancer: a feasibility study. Magn Reson Med 67(3):778–785PubMedCrossRef Barrett T, Gill AB, Kataoka MY, et al. (2012) DCE and DW MRI in monitoring response to androgen deprivation therapy in patients with prostate cancer: a feasibility study. Magn Reson Med 67(3):778–785PubMedCrossRef
34.
Zurück zum Zitat Panebianco V, Barchetti F, Grompone MD, et al. (2016) Magnetic resonance imaging for localization of prostate cancer in the setting of biochemical recurrence. Urol Oncol 34(7):303–310PubMedCrossRef Panebianco V, Barchetti F, Grompone MD, et al. (2016) Magnetic resonance imaging for localization of prostate cancer in the setting of biochemical recurrence. Urol Oncol 34(7):303–310PubMedCrossRef
35.
Zurück zum Zitat Lista F, Gimbernat H, Cáceres F, et al. (2014) Multiparametric magnetic resonance imaging for the assessment of extracapsular invasion and other staging parameters in patients with prostate cancer candidates for radical prostatectomy. Actas Urol Esp 38(5):290–297PubMedCrossRef Lista F, Gimbernat H, Cáceres F, et al. (2014) Multiparametric magnetic resonance imaging for the assessment of extracapsular invasion and other staging parameters in patients with prostate cancer candidates for radical prostatectomy. Actas Urol Esp 38(5):290–297PubMedCrossRef
36.
Zurück zum Zitat Kasel-Seibert M, Lehmann T, Aschenbach R, et al. (2016) Assessment of PI-RADS v2 for the detection of prostate cancer. Eur J Radiol 85(4):726–731PubMedCrossRef Kasel-Seibert M, Lehmann T, Aschenbach R, et al. (2016) Assessment of PI-RADS v2 for the detection of prostate cancer. Eur J Radiol 85(4):726–731PubMedCrossRef
37.
Zurück zum Zitat Vargas HA, Hötker AM, Goldman DA, et al. (2016) Updated prostate imaging reporting and data system (PIRADS v2) recommendations for the detection of clinically significant prostate cancer using multiparametric MRI: critical evaluation using whole-mount pathology as standard of reference. Eur Radiol 26(6):1606–1612PubMedCrossRef Vargas HA, Hötker AM, Goldman DA, et al. (2016) Updated prostate imaging reporting and data system (PIRADS v2) recommendations for the detection of clinically significant prostate cancer using multiparametric MRI: critical evaluation using whole-mount pathology as standard of reference. Eur Radiol 26(6):1606–1612PubMedCrossRef
38.
Zurück zum Zitat Bratan F, Melodelima C, Souchon R, et al. (2014) How accurate is multiparametric MR imaging in evaluation of prostate cancer volume? Radiology 275(1):144–154PubMedCrossRef Bratan F, Melodelima C, Souchon R, et al. (2014) How accurate is multiparametric MR imaging in evaluation of prostate cancer volume? Radiology 275(1):144–154PubMedCrossRef
39.
Zurück zum Zitat Purysko AS, Bittencourt LK, Bullen JA, et al. (2017) Accuracy and interobserver agreement for prostate imaging reporting and data system, version 2, for the characterization of lesions identified on multiparametric MRI of the prostate. Am J Roentgenol 209(2):339–349CrossRef Purysko AS, Bittencourt LK, Bullen JA, et al. (2017) Accuracy and interobserver agreement for prostate imaging reporting and data system, version 2, for the characterization of lesions identified on multiparametric MRI of the prostate. Am J Roentgenol 209(2):339–349CrossRef
Metadaten
Titel
Investigating the role of DCE-MRI, over T2 and DWI, in accurate PI-RADS v2 assessment of clinically significant peripheral zone prostate lesions as defined at radical prostatectomy
verfasst von
Mehdi Taghipour
Alireza Ziaei
Francesco Alessandrino
Elmira Hassanzadeh
Mukesh Harisinghani
Mark Vangel
Clare M. Tempany
Fiona M. Fennessy
Publikationsdatum
25.10.2018
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 4/2019
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-018-1807-6

Weitere Artikel der Ausgabe 4/2019

Abdominal Radiology 4/2019 Zur Ausgabe

Classics in Abdominal Radiology

The “linguine” sign

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.